Society for Immunotherapy of Cancer (SITC)
Chuck Kolawole is a seasoned communications professional with a diverse background in public relations, digital marketing, and social media management. Currently serving as the Communications Manager at the Society for Immunotherapy of Cancer since June 2022, Chuck previously held positions as a Public Relations Specialist at Hoffman York and as a Digital Marketing Coordinator for the Milwaukee Tech Hub Coalition. Additional experience includes serving as a Social Media Manager at Marquette University and a Camp Counselor with the Jewish Community Center. Chuck's career began as a Sales Associate at Make A Change Advertising, Inc. A graduate of Marquette University, Chuck holds a Bachelor's degree in Advertising, earned between 2018 and 2022.
Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC has more than 2,000 members who represent 22 medical specialties in 42 countries around the world. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.